ANGALA BRYSON: Open Payments
NPI 1831773449 · ROOSEVELT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 11 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $281 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $99 |
| Exeltis, USA Inc. | 1 | $67 |
| Amgen Inc. | 1 | $38 |
| Novo Nordisk Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: VRAYLAR, TWIRLA, EVENITY, Wegovy, Sunosi, AIRSUPRA, QULIPTA, TREMFYA.
Industry payments across UT — which companies pay providers there.
